[1] FIRE A，XU S，MONTGOMERY M K，et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J] .Nature，1998，391(6669)：806-811. [2] TIJSTERMAN M，KETTING R F，PLASTERK R H. The genetics of RNA silencing[J] .Annu Rev Genet，2002，36：489-519. [3] RAY K M，LEUNG P A.RNA interference： from gene silencing to gene-specific therapeutics[J] .Pharmacol Ther，2005，107（2）：222-239. [4] DEEPAK A G. RNA interference & inhibition of viruses[J] . Indian J Med Res，2005，121（3）：147-150. [5] NEKHAI S, JEREBTSOVA M.Therapies for HIV with RNAi[J] . Curr Opin Mol Ther，2006，8(1)：52-61. [6] DELGADO R, REGUEIRO B J.The future of HIV infection： gene therapy and RNA interference[J] .Enferm Infecc Microbiol Clin，2005，23(suppl 2)：76-83. [7] STRAYER D S, AKKINA R, BUNNELL B A，et al.Current status of gene therapy strategies to treat HIV/AIDS[J] .Mol Ther，2005，11（6）：823-842. [8] JOSHI P J，NORTH T W，PRASAD V R. Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication[J] .Mol Ther，2005，11(5)：677-686. [9] TER BRAKE O，BERKHOUT B.A novel approach for inhibition of HIV-1 by RNA interference： counteracting viral escape with a second generation of siRNAs[J] .J RNAi Gene Silencing，2005，1(2)：56-65. [10] WESTERHOUT E M，OOMS M，VINK M，et al. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome[J] .Nucleic Acids Res，2005，33(2)：796-804. [11] BENNASSER Y, LE S Y, BENKIRANE M，et al.Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing[J] . Immunity，2005，22(5)：607-619. [12] NOVINA C D，MURRAY M F，DYKXHOORN D M，et al. siRNAdirected inhibition of HIV-1 infection[J] .Nat Med，2002，8(7)：681-686. [13] KITABWALA M，RUPRECHT R M.RNA Interference-a new weapon against HIV and beyond[J] .N Ergl J Med，2002，347(17)：1364-1367. [14] QIN X F，AN D S，CHEN I S，et al. Inhibiting HIV-1 infection in human T cells by lentiviral- mediated delivery of small interfering RNA against CCR5[J] .Proc Natl Acad Sci USA，2003，100(11)：183-188. [15] ANDERSON J，BANERJEA A，PIANELLES V，et al.Potent suppression of HIV type l infection by a short hairpin anti-CXCR4 siRNA[J] .AIDS Res Hum Retroviruses，2003，l9(8)：699-706. [16] ZHOU N, FANG J, MUKHTAR M，et al.Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4[J] .Gene Ther，2004，11(23)：1703-1712. [17] ANDERSON J ，AKKINA R. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector[J] .AIDS Res Ther，2005，2 (1) ：1. [18] ROSCIC-MRKIC B, FISCHER M, LEEMANN C，et al.RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement[J] . Blood，2003，102(4)：1169-1177. [19] ARRIGHI J F，PION M，GARCIA E，et al . DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells[J] .J Exp Med，2004，200(10)：1279-1288. [20] ARRIGHI J F，PION M，WIZNEROWICZ M，et al. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodefi ciency virus transmission from dendritic cells to T cells[J] .J Virol，2004，78（20）：10848-10855. [21] NARI M P, REYNOLDS J L, MAHAJAN S D，et al. RNAi-directed inhibition of DC-SIGN by dendritic cells： Prospects for HIV-1 therapy[J] .AAPS，2005，7(3)：572-578. [22] CHIU Y L ，CAO H ，JACQUE J M ，et al. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1) [J] .J Virol，2004 ，78 (5) ：2517-2529. [23] LI Z, XIONG Y, PENG Y，et al.Specific inhibition of HIV-1 replication by short hairpin RNAs targeting human cyclin T1 without inducing apoptosis[J] .FEBS Lett，2005，579(14)：3100-3106. [24] PING Y H, CHU C Y, CAO H，et al.Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5[J] .Retrovirology，2004，1（46）：1-13. [25] SURABHI R M，GAYNOR R B. RNA interference directed against viral and cellular targets inhibits human immu-nodeficiency Virus Type 1 replication[J] .J Virol，2002，76（24）：12963-12973. [26] ZIMMERMAN C，KLEIN K C，KISER P K，et al. Identification of a host protein essential for assembly of immature HIV-1 capsids[J] .Nature，2002，415（6867）：88-92. [27] MARTIN-SERRANO J，ZANG T，BIENIASZ P D.HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress[J] .Nat Med，2001，7（12）：1313-1319. [28] GARRUS J E，VON SCHWEDLER U K，PORNILLOS O W，et al.Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding[J] .Cell，2001，107（1）：55-65. [29] OTA K M，KAMEOKA Y，TANAKA A，et al. Expression of histone acetyltransferases was down-regulated in poly(ADP-ribose) polymerase-1-deficient murine cells[J] .Biochem Biophys Res Commun，2003，310（2）：312-317. [30] KAMEOKA M，NUKUZUMA S，ITAYA A，et al.RNA Interference directed against poly(ADP-Ribose) polymerase 1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells[J] .J Virol，2004，78（16）：8931-8934. [31] LIU S，ASPARUHOVA M，BRONDANI V，et al. Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A[J] .Nucleic Acids Res，2004，32(12)：3752-3759. [32] HAUBER I，BEVEC D，HEUKESHOVEN J，et al.Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy[J] .J Clin Invest，2005，115(1)：76-85. [33] YU Z, SANCHEZ-VELAR N, CATRINA I E，et al.The cellular HIV-1 Rev cofactor hRIP is required for viral replication[J] .Proc Natl Acad Sci USA，2005，102(11)：4027-4032. [34] AMMOSOVA T, BERRO R, KASHANCHI F，et al.RNA interference directed to CDK2 inhibits HIV-1 transcription[J] . Virology，2005，341(2)：171-178. [35] HENGLI T，TAO P，FLOSSIE W S.Novel technologies for studying virus host interaction and discovering new drug targets for HCV and HIV[J] .Curr Opin Pharmacol，2002，2（5）：541-547. [36] IORDANSKIY S, ZHAO Y, DUBROVSKY L，et al. Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R[J] .J Virol，2004，78(18)：9697-9704.